<HashMap><database>biostudies-arrayexpress</database><scores/><additional><omics_type>Metabolomics</omics_type><omics_type>Unknown</omics_type><omics_type>Transcriptomics</omics_type><omics_type>Genomics</omics_type><omics_type>Proteomics</omics_type><submitter>KIYOUNG EUN</submitter><instrument_platform>Illumina NovaSeq 6000</instrument_platform><study_type>RNA-seq of total RNA</study_type><organism>Homo sapiens</organism><species>Homo sapiens</species><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/E-MTAB-16032</full_dataset_link><description>Through a metabolic RNAi-based screen for cell invasion, potential metastatic functions of AASS were identified. This study was to investigate the role of AASS and its metabolic product, α-aminoadipate (2-AAA), in the metastatic potential of lung adenocarcinoma. H1299 lung adenocarcinoma cells were infected with a pLKO.1-based lentiviral vector carrying shRNA targeting AASS. Poly-A RNA sequencing was then performed on control and AASS-knockdown H1299 cells to assess differentially expressed genes modulated by AASS depletion.</description><repository>biostudies-arrayexpress</repository><sample_protocol>Library Construction - Approximately 2 ug of total RNA was subjected to isolate Poly (A) mRNA with poly-T oligo attached magnetic beads (Invitrogen). Following purification, the poly(A) mRNA fractions is fragmented into small pieces using divalent cations under elevated temperature. Then the cleaved RNA fragments were reverse-transcribed to create the final cDNA library in accordance with a strand-specific library preparation by dUTP method. The average insert size for the paired-end libraries was 300±50 bp.</sample_protocol><sample_protocol>Sample Collection - Cells were collected by Trypsization and washed with PBS twice.</sample_protocol><sample_protocol>Nucleic Acid Extraction - After cell collection, total RNA was extracted using the RNeasy Kit (QIAGEN) according to the manufacturer’s instructions.</sample_protocol><sample_protocol>Sequencing - RNAseq was performed by LC Sciences (Huston, TX, Unites States) through the Illumina NovaSeq 6000 platform.</sample_protocol><sample_protocol>Growth Protocol - All cells were cultured in RPMI medium supplemented with 10% FBS and 1% penicillin–streptomycin.</sample_protocol><figure_sub>Organization</figure_sub><figure_sub>MINSEQE Score</figure_sub><figure_sub>Assays and Data</figure_sub><figure_sub>MAGE-TAB Files</figure_sub><pubmed_authors>KIYOUNG EUN</pubmed_authors></additional><is_claimable>false</is_claimable><name>Transcriptomic analysis of AASS-knockdown H1299 cells to identify its role in metastatic potential of lung adenocarcinoma</name><description>Through a metabolic RNAi-based screen for cell invasion, potential metastatic functions of AASS were identified. This study was to investigate the role of AASS and its metabolic product, α-aminoadipate (2-AAA), in the metastatic potential of lung adenocarcinoma. H1299 lung adenocarcinoma cells were infected with a pLKO.1-based lentiviral vector carrying shRNA targeting AASS. Poly-A RNA sequencing was then performed on control and AASS-knockdown H1299 cells to assess differentially expressed genes modulated by AASS depletion.</description><dates><release>2026-02-28T00:00:00Z</release><modification>2026-02-28T02:02:14.844Z</modification><creation>2025-11-04T09:36:25.163Z</creation></dates><accession>E-MTAB-16032</accession><cross_references><ENA>ERP183656</ENA><EFO>EFO_0002944</EFO><EFO>EFO_0004170</EFO><EFO>EFO_0009653</EFO><EFO>EFO_0003789</EFO><EFO>EFO_0005518</EFO><EFO>EFO_0004184</EFO></cross_references></HashMap>